We are live on ! Find out more
LAB icon

Standard BioTools
LAB

100 hedge funds and large institutions have $229M invested in Standard BioTools in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

13% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $1.01M

6% less funds holding

Funds holding: 106 → 100 (-6)

25% less capital invested

Capital invested by funds: $306M → $229M (-$77.2M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
2.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
35
Reduced
29
Closed
23
Calls
$1.14M
Puts
$1.01M
Net Calls
+$133K
Net Calls Change
-$9.86M

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$15.1M
2
RFC
Russell Frank Company
Washington
+$8.17M
3
Jennison Associates
Jennison Associates
New York
+$3.13M
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$2.46M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.43M

Top Sellers

1
SCM
Scopia Capital Management
New York
-$16.3M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$6.62M
3
O
OrbiMed
New York
-$5.08M
4
Goldman Sachs
Goldman Sachs
New York
-$4.37M
5
HCMT
Highland Capital Management (Texas)
Texas
-$2.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$1.28M -$763K -105,808 -40%
SM
27
Sabby Management
Florida
$1.13M -$899K -124,690 -47%
PVI
28
Pura Vida Investments
New York
$1.01M +$902K +125,000 New
Renaissance Technologies
29
Renaissance Technologies
New York
$872K -$700K -97,000 -47%
TCIM
30
TIAA CREF Investment Management
New York
$866K -$23.7K -3,288 -3%
BIM
31
BlackRock Investment Management
Delaware
$835K +$12K +1,670 +2%
IHM
32
Iguana Healthcare Management
New York
$807K +$721K +100,000 New
Ohio Public Employees Retirement System (OPERS)
33
Ohio Public Employees Retirement System (OPERS)
Ohio
$735K +$66K +9,158 +11%
Charles Schwab
34
Charles Schwab
California
$718K +$11.8K +1,632 +2%
Principal Financial Group
35
Principal Financial Group
Iowa
$639K – – –
Federated Hermes
36
Federated Hermes
Pennsylvania
$570K +$5.74K +796 +1%
CS
37
Credit Suisse
Switzerland
$553K +$325K +45,108 +193%
PC
38
Polar Capital
United Kingdom
$520K +$99.3K +13,775 +27%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$507K -$28.1K -3,900 -6%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$492K +$55K +7,626 +14%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$397K -$2.16K -300 -0.6%
TA
42
Teachers Advisors
New York
$381K – – –
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$371K +$332K +46,000 New
OPPM
44
Opus Point Partners Management
New York
$363K -$180K -25,000 -36%
Swiss National Bank
45
Swiss National Bank
Switzerland
$354K +$67.1K +9,300 +26%
WMSA
46
Weiss Multi-Strategy Advisers
New York
$323K +$216K +30,000 +300%
AllianceBernstein
47
AllianceBernstein
Tennessee
$310K -$10.1K -1,400 -4%
EGM
48
Engineers Gate Manager
New York
$277K +$248K +34,382 New
Capital Fund Management (CFM)
49
Capital Fund Management (CFM)
France
$233K +$208K +28,873 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$224K +$721 +100 +0.4%
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2016 in Review

100 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2016, worth a combined $229M — down 25% from $306M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of LAB and 17 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 35 added.

The largest buyer was Levin Capital Strategies, opening a new position worth an estimated $15.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.3M sold.

  • 100 institutional investors held Standard BioTools (LAB) as of Q1 2016, down from 106 in Q4 2015.
  • Funds reported $229M of Standard BioTools stock for Q1 2016, down 25% quarter-over-quarter.
  • 17 funds opened new Standard BioTools positions in Q1 2016 and 23 closed out, a net change of -6 holders.
  • The largest Standard BioTools buyer in Q1 2016 was Levin Capital Strategies, an estimated $15.1M added.
  • The largest Standard BioTools seller in Q1 2016 was Scopia Capital Management, an estimated $16.3M sold.

Based on aggregated 13F filings for Q1 2016.